Trial Condition(s):
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
1401663
Not Available
Not Available
To show efficacy of Zarzenda in the treatment of hand eczema
- Mild to moderate hand eczema for at least 3 months - At least 4 weeks have passed since use of systemic treatment for eczema - At least 4 weeks have passed since any vaccination - At least 1 week has passed since last topic treatment on hands with corticosteroids - Agree to use adequate contraceptive method if of childbearing potential - Willingness to avoid excessive exposure to sunlight and avoid skin irritants
- Pregnancy, breast feeding - Severe excoriations on the hands - Need for systemic treatment for atopic dermatitis - Known sensitivity to Zarzenda and/or to extract of nut butyrospermum parkii (shea) - Known immune deficiency - Concomitant infection on hands
Locations | Status | |
---|---|---|
Locations Intendis GmbH Berlin, Germany | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema
Trial Type:
Interventional
Intervention Type:
Device
Trial Purpose:
Treatment
Allocation:
N/A
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1